Revance Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking

Revance Therapeutics, Inc. Website Screenshot

Revance Therapeutics, Inc. Company Intro

By selecting "I accept," I authorize Revance, or any contracted third parties acting on its behalf, to install cookies on my browser. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media.



Revance Therapeutics, Inc. Headquaters

7555 Gateway Boulevard
United States

Revance Therapeutics, Inc. Share price

01 Dec 2021 15:35 GMT


-0.04 (-0.29 %)

Revance Therapeutics, Inc. Market cap

$1.024 B



Revance Therapeutics, Inc. # 285


Latest Revance Therapeutics, Inc. News

News 07 Aug 2021

Botulinum Toxin Market Size, Growth Drivers, Regional ...

Ltd., Merz Pharma GmbH & Co. KgaA, US Worldmed LLC, Allergan Revance Therapeutics Ipsen Group, Medytox Nestlé Skin Health, Hugel Inc., Metabiologics, Inc.

News 07 Aug 2021

Revance Therapeutics Inc. (NASDAQ: RVNC) Down Almost ...

Revance Therapeutics Inc. (NASDAQ:RVNC)'s traded shares stood at 0.71 million during the last session, with the company's beta value hitting 1.25.

News 07 Aug 2021

Gets Its Catalyst And Trades Up: Revance Therapeutics Inc ...

ASSENAGON ASSET MANAGEMENT SA (G bought a fresh place in Revance Therapeutics Inc. (NASDAQ:RVNC). The institutional investor bought 141.8 thousand shares of ...

WMC Market Score

WMC Market to Revenue Score

Revance Therapeutics, Inc. Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Revance Therapeutics, Inc. USD $28,566 $301,794 $-291,795 $10,240B 285
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $685,150B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $515,660B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $148,930B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Revance Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors

Revance Therapeutics, Inc. Post vs Top 4 Industry Competitors

Revance Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors

Revance Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors

Revance Therapeutics, Inc. WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Revance Therapeutics, Inc. 0.31 0.49 0.09 0 0 0 0.22
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 100 0 0 54.46
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 86 0 0 50.16
Alexion Pharmaceuticals, Inc. 68.08 100 100 60 0 0 100
Incyte Corporation 29.39 5.03 0.04 2 0 0 2.88

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb